Full text is available at the source.
Abstract
Most endometrial cancers (EC) are associated with obesity.
- Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective medications for weight loss.
- Utilization of GLP-1RAs in the context of endometrial cancer remains largely unexplored.
- Understanding the use of weight loss medications could be important for managing obesity-related endometrial cancer.
Simplified